Dietary flavonols intake and risk of esophageal and gastric cancer: A meta-analysis of epidemiological studies

Nutrients

Volumn 8, Issue 2, 2016, Pages

  Xie, Yan ^a   Huang, Shifeng ^a   Su, Yuxi ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Epidemiology; Esophageal and gastric cancer; Flavonols; Meta analysis

Indexed keywords

FLAVONOL; FLAVONOL DERIVATIVE; PLANT EXTRACT;

ALCOHOL CONSUMPTION; ARTICLE; CALORIC INTAKE; CANCER RISK; CARDIA CARCINOMA; DATA EXTRACTION; DIETARY INTAKE; DISEASE ASSOCIATION; ESOPHAGUS CANCER; HUMAN; META ANALYSIS (TOPIC); NONCARDIA GASTRIC ADENOCARCINOMA; SENSITIVITY ANALYSIS; SMOKING; STOMACH ADENOCARCINOMA; ADENOCARCINOMA; DIET; ESOPHAGEAL NEOPLASMS; FEMALE; MALE; META ANALYSIS; STOMACH NEOPLASMS;

ADENOCARCINOMA; DIET; ESOPHAGEAL NEOPLASMS; FEMALE; FLAVONOLS; HUMANS; MALE; PLANT EXTRACTS; SMOKING; STOMACH NEOPLASMS;

EID: 84958530339     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8020091     Document Type: Article

References (43)

1. Global Burden of Disease Cancer Collaboration; Fitzmaurice, C.; Dicker, D.; Pain, A.; Hamavid, H.; Moradi-Lakeh, M.; MacIntyre, M.F.; Allen, C.; Hansen, G.; Woodbrook, R.; et al. The Global Burden of Cancer 2013. JAMA Oncol. 2015, 1, 505-527. [CrossRef] [PubMed].
2. Torre, L.A.; Bray, F.; Siegel, R.L.; Ferlay, J.; Lortet-Tieulent, J.; Jemal, A. Global cancer statistics, 2012. CA Cancer J. Clin. 2015, 65, 87-108. [CrossRef] [PubMed].
3. Devesa, S.S.; Blot, W.J.; Fraumeni, J.F., Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998, 83, 2049-2053. [CrossRef].
4. Simard, E.P.; Ward, E.M.; Siegel, R.; Jemal, A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J. Clin. 2012, 62, 118-128. [CrossRef] [PubMed].
5. Wijnhoven, B.P.; Siersema, P.D.; Hop,W.C.; van Dekken, H.; Tilanus, H.W. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br. J. Surg. 1999, 86, 529-535. [CrossRef] [PubMed].
6. Abnet, C.C.; Corley, D.A.; Freedman, N.D.; Kamangar, F. Diet and upper gastrointestinal malignancies. Gastroenterology 2015, 148, 1234-1243.e4. [CrossRef] [PubMed].
7. Somi, M.H.; Mousavi, S.M.; Naghashi, S.; Faramarzi, E.; Jafarabadi, M.A.; Ghojazade, M.; Majidi, A.; Naseri Alavi, S.A. Is there any relationship between food habits in the last two decades and gastric cancer in North-Western Iran? Asian Pac. J. Cancer Prev. 2015, 16, 283-290. [CrossRef] [PubMed].
8. Lin, S.H.; Li, Y.H.; Leung, K.; Huang, C.Y.;Wang, X.R. Salt processed food and gastric cancer in a Chinese population. Asian Pac. J. Cancer Prev. 2014, 15, 5293-5298. [CrossRef] [PubMed].
9. Wang, Z.M.; Zhao, D.; Nie, Z.L.; Zhao, H.; Zhou, B.; Gao, W.; Wang, L.S.; Yang, Z.J. Flavonol intake and stroke risk: A meta-analysis of cohort studies. Nutrition 2014, 30, 518-523. [CrossRef] [PubMed].
10. Chang, H.; Xie, Q.; Zhang, Q.Y.; Peng, X.L.; Zhu, J.D.; Mi, M.T. Flavonoids, flavonoid subclasses and breast cancer risk: A meta-analysis of epidemiologic studies. PLoS ONE 2013, 8, e54318.
11. Miles, S.L.; McFarland, M.; Niles, R.M. Molecular and physiological actions of quercetin: need for clinical trials to assess its benefits in human disease. Nutr. Rev. 2014, 72, 720-734. [CrossRef] [PubMed].
12. Xue,W.; Song, B.A.; Zhao, H.J.; Qi, X.B.; Huang, Y.J.; Liu, X.H. Novel myricetin derivatives: Design, synthesis and anticancer activity. Eur. J. Med. Chem. 2015, 97, 155-163. [CrossRef] [PubMed].
13. Greenland, S. Quantitative methods in the review of epidemiologic literature. Epidemiol. Rev. 1987, 9, 1-30. [PubMed].
14. Mantel, N.; Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22, 719-748. [PubMed].
15. DerSimonian, R.; Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7, 177-188. [CrossRef].
16. Ioannidis, J.P.; Ntzani, E.E.; Trikalinos, T.A.; Contopoulos-Ioannidis, D.G. Replication validity of genetic association studies. Nat. Genet. 2001, 29, 306-309. [CrossRef] [PubMed].
17. Petrick, J.L.; Steck, S.E.; Bradshaw, P.T.; Trivers, K.F.; Abrahamson, P.E.; Engel, L.S.; He, K.; Chow, W.H.; Mayne, S.T.; Risch, H.A.; et al. Dietary intake of flavonoids and oesophageal and gastric cancer: incidence and survival in the United States of America (USA). Br. J. Cancer 2015, 112, 1291-1300. [CrossRef] [PubMed].
18. Vermeulen, E.; Zamora-Ros, R.; Duell, E.J.; Luján-Barroso, L.; Boeing, H.; Aleksandrova, K.; Bueno-de-Mesquita, H.B.; Scalbert, A.; Romieu, I.; Fedirko, V.; et al. Dietary flavonoid intake and esophageal cancer risk in the European prospective investigation into cancer and nutrition cohort. Am. J. Epidemiol. 2013, 178, 570-581. [CrossRef] [PubMed].
19. Bobe, G.; Peterson, J.J.; Gridley, G.; Hyer, M.; Dwyer, J.T.; Brown, L.M. Flavonoid consumption and esophageal cancer among black and white men in the United States. Int. J. Cancer 2009, 125, 1147-1154. [CrossRef] [PubMed].
20. Rossi, M.; Garavello, W.; Talamini, R.; La Vecchia, C.; Franceschi, S.; Lagiou, P.; Zambon, P.; Dal Maso, L.; Bosetti, C.; Negri, E. Flavonoids and risk of squamous cell esophageal cancer. Int. J. Cancer 2007, 120, 1560-1564. [CrossRef] [PubMed].
21. Ekström, A.M.; Serafini, M.; Nyrén, O.; Wolk, A.; Bosetti, C.; Bellocco, R. Dietary quercetin intake and risk of gastric cancer: Results from a population-based study in Sweden. Ann. Oncol. 2011, 22, 438-443. [CrossRef] [PubMed].
22. Woo, H.D.; Lee, J.; Choi, I.J.; Kim, C.G.; Lee, J.Y.; Kwon, O.; Kim, J. Dietary flavonoids and gastric cancer risk in a Korean population. Nutrients 2014, 6, 4961-4973. [CrossRef] [PubMed].
23. Zamora-Ros, R.; Agudo, A.; Luján-Barroso, L.; Romieu, I.; Ferrari, P.; Knaze, V.; Bueno-de-Mesquita, H.B.; Leenders, M.; Travis, R.C.; Navarro, C.; et al. Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am. J. Clin. Nutr. 2012, 96, 1398-1408. [CrossRef] [PubMed].
24. Rossi, M.; Rosato, V.; Bosetti, C.; Lagiou, P.; Parpinel, M.; Bertuccio, P.; Negri, E.; La Vecchia, C. Flavonoids, proanthocyanidins, and the risk of stomach cancer. Cancer Causes Control. 2010, 21, 1597-1604. [CrossRef] [PubMed].
25. Lagiou, P.; Samoli, E.; Lagiou, A.; Peterson, J.; Tzonou, A.; Dwyer, J.; Trichopoulos, D. Flavonoids, vitamin C and adenocarcinoma of the stomach. Cancer Causes Control. 2004, 15, 67-72. [CrossRef] [PubMed].
26. Knekt, P.; Kumpulainen, J.; Järvinen, R.; Rissanen, H.; Heliövaara, M.; Reunanen, A.; Hakulinen, T.; Aromaa, A. Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 2002, 76, 560-568. [PubMed].
27. Hirvonen, T.; Virtamo, J.; Korhonen, P.; Albanes, D.; Pietinen, P. Flavonol and flavone intake and the risk of cancer in male smokers (Finland). Cancer Causes Control. 2001, 12, 789-796. [CrossRef] [PubMed].
28. Garcia-Closas, R.; Gonzalez, C.A.; Agudo, A.; Riboli, E. Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes Control. 1999, 10, 71-75. [CrossRef] [PubMed].
29. Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics, 2015. CA Cancer J. Clin. 2015, 65, 5-29. [CrossRef] [PubMed].
30. Fedewa, S.A.; Sauer, A.G.; Siegel, R.L.; Jemal, A. Prevalence of major risk factors and use of screening tests for cancer in the United States. Cancer Epidemiol. Biomark. Prev. 2015, 24, 637-652. [CrossRef] [PubMed].
31. Rajesh, E.; Sankari, L.S.; Malathi, L.; Krupaa, J.R. Naturally occurring products in cancer therapy. J. Pharm. Bioallied. Sci. 2015, 7, S181-S183. [CrossRef] [PubMed].
32. Russo, G.L.; Russo, M.; Spagnuolo, C. The pleiotropic flavonoid quercetin: from its metabolism to the inhibition of protein kinases in chronic lymphocytic leukemia. Food Funct. 2014, 5, 2393-2401. [CrossRef] [PubMed].
33. Liu, Y.; Wu, Y.M.; Zhang, P.Y. Protective effects of curcumin and quercetin during benzo(a)pyrene induced lung carcinogenesis in mice. Eur. Rev. Med. Pharmacol. Sci. 2015, 19, 1736-1743. [PubMed].
34. Sak, K. Dependence of DPPH radical scavenging activity of dietary flavonoid quercetin on reaction environment. Mini Rev. Med. Chem. 2014, 14, 494-504. [CrossRef] [PubMed].
35. Miyamoto, N.; Izumi, H.; Miyamoto, R.; Kondo, H.; Tawara, A.; Sasaguri, Y.; Kohno, K. Quercetin induces the expression of peroxiredoxins 3 and 5 via the Nrf2/NRF1 transcription pathway. Invest. Ophthalmol. Vis. Sci. 2011, 52, 1055-1563. [CrossRef] [PubMed].
36. Men, K.; Duan, X.;Wei, X.W.; Gou, M.L.; Huang, M.J.; Chen, L.J.; Qian, Z.Y.;Wei, Y.Q. Nanoparticle-delivered quercetin for cancer therapy. Anticancer Agents Med. Chem. 2014, 14, 826-832. [CrossRef] [PubMed].
37. Tseng, H.L.; Li, C.J.; Huang, L.H.; Chen, C.Y.; Tsai, C.H.; Lin, C.N.; Hsu, H.Y. Quercetin 3-O-methyl ether protects FL83B cells from copper induced oxidative stress through the PI3K/Akt and MAPK/Erk pathway. Toxicol. Appl. Pharmacol. 2012, 264, 104-113. [CrossRef] [PubMed].
38. Lu, Q.; Ji, X.J.; Zhou, Y.X.; Yao, X.Q.; Liu, Y.Q.; Zhang, F.; Yin, X.X. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy. Pharmacol. Res. 2015, 99, 237-247. [CrossRef] [PubMed].
39. Touvier, M.; Druesne-Pecollo, N.; Kesse-Guyot, E.; Andreeva, V.A.; Fezeu, L.; Galan, P.; Hercberg, S.; Latino-Martel, P. Dual association between polyphenol intake and breast cancer risk according to alcohol consumption level: a prospective cohort study. Breast Cancer Res. Treat. 2013, 137, 225-236. [CrossRef] [PubMed].
40. Milenkovic, D.; Vanden Berghe, W.; Boby, C.; Leroux, C.; Declerck, K.; Szarc vel Szic, K.; Heyninck, K.; Laukens, K.; Bizet, M.; Defrance, M.; et al. Dietary flavanols modulate the transcription of genes associated with cardiovascular pathology without changes in their DNA methylation state. PLoS ONE 2014, 9, e95527. [CrossRef] [PubMed].
41. Li, G.; Wulan, H.; Song, Z.; Paik, P.A.; Tsao, M.L.; Goodman, G.M.; MacEachern, P.T.; Downey, R.S.; Jankowska, A.J.; Rabinowitz, Y.M.; et al. Regulatory B Cell Function Is Suppressed by Smoking and Obesity in H. pylori-Infected Subjects and Is Correlated with Elevated Risk of Gastric Cancer. PLoS ONE 2015, 10, e0134591. [CrossRef] [PubMed].
42. De Stefani, E.; Ronco, A.; Mendilaharsu, M.; Deneo-Pellegrini, H. Diet and risk of cancer of the upper aerodigestive tract-II. Nutrients.Oral Oncol. 1999, 35, 22-26. [CrossRef].
43. Woo, H.D.; Kim, J. Dietary flavonoid intake and risk of stomach and colorectal cancer. World J. Gastroenterol. 2013, 19, 1011-1019. [CrossRef] [PubMed].